Table 3. Clinical Characteristics of Achalasia Patients.
| Feature | |
|---|---|
| Gender (male/female) | 10:8 |
| Age (mean, SD, range) (years) | 60.7 (13), 34 - 81 |
| Duration of achalasia (mean, SD, range) (months) | 79 (114), 1 - 480 |
| Type of achalasia (N = 18), N (%) | |
| Type I | 1 (5.6) |
| Type II | 9 (50.0) |
| Type III | 2 (11.0) |
| Esophageal gastric outlet obstruction | 5 (27.8) |
| Unspecified type | 1 (5.6) |
| Prior myotomy, N (%) | 2 (11.0) |
| Endoscopic findings (N = 18), N (%) | |
| Dilated esophagus only | 15 (83.3) |
| Dilated esophagus with esophagitis | 2 (11.1) |
| Dilated esophagus with diverticulum | 1 (5.6) |
| Timed barium study (N = 17), N (%) | |
| Dilated esophagus | 6 (35.3) |
| Dilated esophagus with delayed passage of barium | 7 (41.2) |
| Normal examination | 4 (23.5) |
| PPI use (N = 18), N (%) | |
| Omeprazole 40 daily | 6 (33.3) |
| Omeprazole 40 mg bid | 3 (16.7) |
| Lansoprazole 15 mg daily | 1 (5.6) |
| Unspecified | 1 (5.6) |
| None | 7 (38.8) |
SD: standard deviation; PPI: proton pump inhibitor.